MYC Variant rs7824364: Prostate Cancer Risk and Ancestry
The genetic variant rs7824364 is a single-nucleotide polymorphism located in the 8q24 chromosomal region. It has been identified in research studies as being associated with an increased risk of prostate cancer, particularly in men of West African and Puerto Rican ancestry.
What each genotype means
Baseline prostate cancer risk
This genotype represents the absence of the minor risk allele associated with this specific 8q24 variant. Research indicates that individuals without the minor allele do not carry this specific genetic association for increased prostate cancer risk observed in certain populations.
This is the most common genotype in populations with low West African ancestry.
Increased prostate cancer risk
Carrying one copy of the minor allele is associated with an increased risk of prostate cancer in men of West African and Puerto Rican ancestry. This variant is located in a non-coding region of the 8q24 gene desert, and while its exact biological mechanism is still being studied, it is statistically linked to higher susceptibility in these specific groups.
This genotype is more frequently observed in individuals of West African ancestry compared to other populations.
Elevated prostate cancer risk
Carrying two copies of the minor allele is associated with a higher statistical risk of prostate cancer in men of West African and Puerto Rican ancestry. Research suggests that individuals with this genotype may have a higher likelihood of positive biopsy results in clinical settings, though this remains a complex trait influenced by multiple factors.
This genotype is most common in individuals of West African ancestry and is less frequently found in other global populations.
Understanding the rs7824364 Variant
The rs7824364 variant is a specific change in the DNA sequence located on chromosome 8 at the 8q24 locus. In genetics, a single-nucleotide polymorphism (SNP) represents a variation at a single position in the DNA building blocks, known as nucleotides. The 8q24 region is well-known in cancer research because it is a 'gene desert,' meaning it contains very few protein-coding genes but is highly enriched with regulatory elements that control the activity of nearby genes. Because this variant sits in a non-coding region, it does not change the structure of a protein directly. Instead, researchers investigate whether it acts as a regulatory switch that influences how genes in the vicinity are turned on or off. While the exact biological mechanism remains a subject of ongoing scientific inquiry, its location near important regulatory hubs makes it a significant focus for understanding inherited cancer susceptibility.
The Role of the MYC Gene
The rs7824364 variant is often discussed in the context of the MYC gene, which is located nearby on chromosome 8. MYC is a well-characterized proto-oncogene, meaning it plays a critical role in normal cell growth and division. When functioning correctly, MYC helps regulate the cell cycle; however, if its expression becomes dysregulated, it can contribute to the uncontrolled cell growth characteristic of cancer. Because 8q24 acts as a regulatory region, scientists have long hypothesized that variants like rs7824364 might influence the expression levels of MYC in prostate tissue. Despite this strong biological hypothesis, studies examining prostate tissue samples have not always found a direct, consistent link between the presence of this specific variant and altered MYC protein or RNA levels. This suggests that the relationship between the variant and cancer risk may involve complex interactions that are not yet fully understood.
Evidence and Statistical Associations
Research into rs7824364 has primarily focused on its statistical association with prostate cancer risk. Studies have observed that individuals carrying the risk allele show a higher likelihood of developing prostate cancer compared to those who do not. For example, some clinical research has indicated that carriers of the variant may face a more than twofold increased risk of a positive prostate biopsy. It is important to note that the evidence for this association is considered limited in scope and is highly dependent on ancestry. While the statistical signal is strong in specific cohorts of West African and Puerto Rican men, these findings do not necessarily translate to the same level of risk across all global populations. The association is a tool for researchers to understand population-level health disparities, but it is not a definitive diagnostic test for an individual's personal health outcome.
Population Frequency and Ancestry
The frequency of the rs7824364 variant varies significantly across different human populations. Scientific literature consistently highlights that this variant is more common in individuals of West African ancestry. This distribution is a key reason why the variant is studied in the context of health disparities, as it may contribute to the observed differences in prostate cancer incidence rates among various racial and ethnic groups. Because the variant is more prevalent in certain ancestral backgrounds, it serves as a marker that helps scientists map the genetic architecture of disease risk. Understanding these frequency differences is essential for ensuring that genetic research is inclusive and that findings are interpreted correctly within the context of a person's genetic heritage.
Interpreting Your Genetic Information
If you have information about your status for the rs7824364 variant, it is important to view it as one small piece of a much larger puzzle. Genetic risk factors are rarely deterministic; they represent statistical probabilities rather than medical certainties. Having a risk-associated genotype does not mean an individual will develop prostate cancer, nor does the absence of the variant guarantee protection. This information should never be used to make personal health decisions or to diagnose a condition. If you are concerned about your prostate health or your family history of cancer, the most appropriate step is to consult with a healthcare professional or a genetic counselor. They can provide context based on your full medical history, lifestyle factors, and clinical screening guidelines, which are far more predictive of individual health outcomes than any single genetic variant.
How common is this variant?
The rs7824364 variant is notably more frequent in populations of West African ancestry compared to other global populations.
Frequently asked questions
Is rs7824364 a diagnostic test for prostate cancer?
No, rs7824364 is not a diagnostic test. It is a genetic marker associated with a statistical increase in risk, but it cannot determine if an individual has or will develop prostate cancer.
Should I change my screening schedule based on this variant?
You should not change your medical screening schedule based on a single genetic variant. Always discuss your personal risk factors, including family history and genetic results, with your doctor to determine the appropriate screening plan for you.
Why is this variant linked to specific ancestries?
Genetic variants often show different frequencies across populations due to historical migration and evolutionary patterns. The higher frequency of rs7824364 in West African ancestry is a reflection of this natural genetic diversity.
Does this variant mean I have a mutation in the MYC gene?
No, this variant is located in a non-coding region near the MYC gene, not within the gene itself. It is thought to potentially influence how the gene is regulated, rather than changing the gene's structure.
Sources & further reading
Educational information only, last refreshed 10/27/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs7824364?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in MYC
This variant is a well-established risk factor for colorectal and prostate cancer susceptibility.
Non-coding variant in the 8q24 region near MYC associated with increased risk of colorectal and prostate cancers.
This non-coding variant on chromosome 8q24 near the MYC proto-oncogene is significantly associated with an increased susceptibility to bladder cancer.
This variant is located in a gene desert near the MYC oncogene and is associated with an increased risk of colorectal and prostate cancers.
An intergenic variant at 7q31.1 demonstrated to associate with physician-diagnosed allergic conditions including allergic rhinitis.